Position in JNJ
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$1,041,277
+$220,692 QoQ
Shares Held
4,100
+22.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.47%
of 13F equity value
Holder Rank
#2,979
of 4,664 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cornerstone Select Advisors, LLC holds $13,220,810 across 7 Drug Manufacturers - General names. JNJ ranks #6 (7.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
13,222 | $3,327,184 | |
| 2 | MRK |
Merck & Co., Inc.
|
25,523 | $3,279,705 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
18,744 | $2,368,116 | |
| 4 | AMGN |
Amgen Inc
|
4,743 | $1,717,535 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
19,000 | $1,094,780 | |
| 6 | JNJ |
Johnson & Johnson
This page
|
4,100 | $1,041,277 | |
| 7 | LLY |
ELI LILLY & Co
|
327 | $392,213 |
All Filings in JNJ
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,041,277 | 4,100 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $820,585 | 3,357 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $668,241 | 3,229 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $586,668 | 3,164 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $417,924 | 2,736 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $469,824 | 2,833 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $386,569 | 2,673 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||